Proteases II pp 345-349 | Cite as

Proteases and Antiproteases at Different Vascular Sites in Renal Failure

  • Kurt Bausewein
  • Klaus Schafferhans
  • Rüdiger Götz
  • Ulrich Gilge
  • Ekkehart Heidbreder
  • August Heidland
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 240)

Abstract

A potential role of proteases in the pathogenesis of the catabolic state in patients with post-traumatic acute renal failure (ARF) has been discussed 1-3. It was suggested that active proteases might play a role in protein wasting observed in uremic conditions4. Since trauma itself might lead to increased plasma proteolysis, the present study was performed both in patients with non-traumatic ARF and chronic renal failure (CRF) to examine potential imbalances between proteases and antiproteases in plasma. Some components of plasma proteolytic enzyme systems were also studied. All parameters were measured in plasma taken at different vascular sites in order to establish as to whether there were any arteriovenous differences across various organs indicating local extraction or release.

Keywords

Catheter Creatinine Trypsin Plasminogen Uremia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    W.H. Hörl and A. Heidland, Enhanced proteolytic activity -cause of protein catabolism in acute renal failure, Am. J. Clin. Nutr. 33: 1423 (1980)PubMedGoogle Scholar
  2. 2.
    W.H. Hörl, J. Stepinski and A. Heidland, Further evidence for the participation of proteases in protein catabolism during hypercatabolic renal failure, in; “Acute renal failure”, H.E. Eliahou, ed., John Libbey, London (1982)Google Scholar
  3. 3.
    W.H. Hörl, J. Stepinski, R.M. Schaefer, C. Wanner and A. Heidland, Role of proteases in hypercatabolic patients with renal failure. Kidney Int. 24: S-37 (1983)CrossRefGoogle Scholar
  4. 4.
    W.H. Hörl, J. Stepinski, C. Gantert, M. Hörl and A. Heidland, Evidence for the participation of proteases in protein catabolism during hypercatabolic renal failure, Klin. Wschr. 59: 751 (1981)PubMedCrossRefGoogle Scholar
  5. 5.
    S. Neumann, G. Gunzer, N. Hennrich and H. Lang, PMN-elastase assay. Enzyme Immunoassay for human polymorphonuclear elastase complexed with (α1-proteinase inhibitor, J. Clin. Chem. Clin. Biochem. 22: 693 (1984)PubMedGoogle Scholar
  6. 6.
    A. Heidland, W.H. Hörl, N. Heller, H. Heine, S. Neumann, R.M. Schaefer and E. Heidbreder, Granulocyte lysosomal factors and plasma elastase in uremia: a potential effect of catabolism. Klin. Wschr. 62: 218 (1984)PubMedCrossRefGoogle Scholar
  7. 7.
    M. Jochum, K.H. Duswald, S. Neumann, J. Witte and H. Fritz, Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. Adv. Exp. Med. Biol. 167: 391 (1984)PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Kurt Bausewein
    • 1
  • Klaus Schafferhans
    • 1
  • Rüdiger Götz
    • 1
  • Ulrich Gilge
    • 1
  • Ekkehart Heidbreder
    • 1
  • August Heidland
    • 1
  1. 1.Department of Medicine, Division of NephrologyUniversity of WuerzburgGermany

Personalised recommendations